Overview

Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

Status:
Completed
Trial end date:
2021-03-09
Target enrollment:
Participant gender:
Summary
Intensity modulated radiation therapy (IMRT) with or without chemotherapy (if given, either cisplatin, cetuximab, or carboplatin-paclitaxel)
Phase:
Phase 2
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Treatments:
Albumin-Bound Paclitaxel
Carboplatin
Cetuximab
Cisplatin
Paclitaxel